Top 5 Stock Picks of Chinese Billionaire Lei Zhang

3. I-Mab (NASDAQ:IMAB)

Hillhouse Capital Management’s Stake Value: $520,685,000

Percentage of Hillhouse Capital Management’s 13F Portfolio: 6.80%

Number of Hedge Fund Holders: 18

I-Mab (NASDAQ:IMAB) is a clinical stage biotech company working on developing innovative medication for multiple cancers and autoimmune diseases. Lei Zhang holds a $520.6 million stake in I-Mab (NASDAQ:IMAB) as of the third quarter, which accounts for 6.8% of his total portfolio of investments.

I-Mab (NASDAQ:IMAB) is increasing its market footprint by acquiring biotech companies such as Roche Diagnostics and collaborating with multiple market players including Jumpcan Pharmaceutical and the Sinopharm Group. 

As of September this year, 18 hedge funds in Insider Monkey’s database of elite funds were bullish on I-Mab (NASDAQ:IMAB), with a total stake value of $837.7 million. This is compared to the same number of funds in the prior quarter, with stakes amounting to  $873.7 million.